Workflow
Inflammation portfolio expansion
icon
Search documents
Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion
WSJ· 2026-03-23 22:55
Gilead said the deal would bolster its growing inflammation portfolio. ...